Loyola University Chicago

Loyola eCommons
Master's Theses

Theses and Dissertations

1969

The Effects of Hydroxyurea on Albino Rat Conceptuses
Michael R. Cozza Jr.
Loyola University Chicago

Follow this and additional works at: https://ecommons.luc.edu/luc_theses
Part of the Medicine and Health Sciences Commons

Recommended Citation
Cozza, Michael R. Jr., "The Effects of Hydroxyurea on Albino Rat Conceptuses" (1969). Master's Theses.
2361.
https://ecommons.luc.edu/luc_theses/2361

This Thesis is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It
has been accepted for inclusion in Master's Theses by an authorized administrator of Loyola eCommons. For more
information, please contact ecommons@luc.edu.
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Copyright © 1969 Michael R. Cozza Jr.

THE EFFECTS OF HYDROXYUREA
ON ALBINO RAT CONCEPTUSES
by
Michael R. Cozza Jr.

A Thesis Submitted to the Faculty of the Graduate School

ot Loyola University in Partial Fulfillment of
the Requirements for the Degree of
Master ot Science
June
1969

library·· Loyola University Mecftcaf Center

LIFE
Michael Richard Cozza Jr. was born in Pittsburgh, Pennsylvania
on May 17, 1939.

In June, 1957, he graduated from Central District

Catholic High School.

He attended Georgetown University for two

years and then Duquesne University where he graduated with a Bachelor
of Science Degree in June 1961.

From 1961 until 1963 he was enrolled

in the University of Pittsburgh as a non-degree student.
He entered the Department of Anatomy in the Graduate School of
Loyola University in September, 1963, and was a graduate teaching
assistant in 1964 and 1965.

In July, 1965, he married Antoinette M.

Manjoine and they have one daughter, Cheray, born June 7, 1966.

From

June, 1965 until September 1967 he was gainfully employed in commerce.
Then he rejoined the Anatomy department and until the present he has
been a graduate teaching assistant.

ii

ACKNOWLEDGEMENT

I wish to express my sincere gratitude to Dr.
Leslie A. Emmert for his suggestion of the problem,
his patience,

encour~gement,

the course of this thesis.

and supervision throughout
His expert guidRnce and

genuine interest in my education were a great source
of strength to me.

My sincere thanks are due Dr. Joseph Thomas
Velardo, Professor and Chairman of the Department of
Anatomy, whose personal example of dedication and
thoughtfulness for others has been a source of great
inspiration.
I would also like to thank Dr. Sigfrid Zitzlsperger,
Professor of Anatomy, for his interest, advice, and
reassurances.
Invaluable help was given to me by my wife,
Antoinette, through her personal sacrifice and her·
faith in me.
My parents deserve my warmest appreciation for
their continued expressions. of confidence.
Finally my thanks go to all members of the
Department of Anatomy for their help.

iii

TABLE OF CONTENTS
Page

INTRODUCTION•••••••••••••••• ••••••••••••••••••••••••••••••••••

1

REVIEW OF LITERATURE••••••••••••••• •••••••••••••••••••••••••••

4

MATERIALS AND METHODS••••••••••••••• ••••••••••••••••••••••••••

13

RESULTS ••••••• , •• • •••••••• • ••••• • ••••••••••••• • •••••• •.• ••••• •

16

Maternal Weights••••••••••••••••••••••••••••••••••••••••••••

16

Fetal Weight and Length•••••••••••••••••••••••••••••••••••••

17

Fetal Morphology••••••••••••••••••••••••••••••••••••••••••••

17

Placentae•••••••••••••••••••••••••••••••••••••••••••••••••••

18

Placental Morphology ••••••••••••••••••••••••••••••••••••••

21

Iron••••••••••••••••••••••••••••••••••••••••••••••••••••••

24

Glycogen, •••••••••••••••••••••••••••••••••••••••••••••••••

25

Metachromasia and Basophilia••••••••••••••••••••••••••••••

27

Calcium ••• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •

28

DISCUSSION ••• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •

30

Fetuses.. • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •

30

Placental Morphology ••••••••••••••••••••••••••••••••••••••••

31

Iron••••••••••••••••••••••••••••••••••••••••••••••••••••••••

34

Glycogen ••••••••••••••••••••••••••••••••••••••••••••••••••••

35

Metachromasia and Baso1)hilia ••••••••••••••••••••••••••• •....

36

Calcium•••••••••••••i•••••••••••••••••••••••••••••••••••••••

37

SUMMARY AND CONCLUSIONS •••••••••••••••••••••••••••••••••••••••

40

BIBLIOGRAPHY ••

••••• 0

•••••••••••••••••••••••••••••••••••••••• 0

42

TABLES •

•

•

•

•·

•••••••••••

47

FIGURES. • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •

54

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

iv

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

0

LIST OF TABLES

Table

I.

II.

III.

IV.
V.

Page

MATERNAL WEIGHTS OF RATS ON DAYS OF INJECTION AND
AT NECROPSY FOLLOWING MATERNAL TREATMENT DURING
GESTATION WITH HYDUOXYUlIBA. • • • • • • • • • • • • • • • • • • • • • • • • • • • •

47

TIIE CONDITION AND NUMBER OF FETUSES AT NECROPSY
FOLLOWING MATERNAL TIIBATMENT DURING GESTATION
WITH HYDROXYUREA. • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •

48

WEIGHT AND CROWN-RUMP LENGTH OF FETUSES AT NECROPSY
FOLLOWING MATERNAL TREATMENT DURING GESTATION WITH
HYDl10XYUIIBA ••••••••••••••••• ; • • • • • • • • • • • • • • • • • • • • • • • • • •

49

A COMPARISON OF PLACENTAL DIAMETERS FROM CONTROL
ANIMALS AND THOSE TREATED WITH HYDROXYUREA •••••••••••••

50

A COMPARISON OF THICKNESS OF LABYRINTHS AND SPONGY
ZONES IN PLACENTAE FROM CONTROL AND HU-TREATED

ANDiALS................................................

51

VI.

HISTOCHEMICAL LOCATION OF IRON DEPOSITS ••••••••••••••••

52

VII.

HISTOCHEMICAL DETECTION OF GLYCOGEN BY PAS •••••••••••••

53

v

LIST OF FIGURES
Figure

1.
2,

3.

4,
5.
6,

7,
8,
90

Page

A LOW POWER PHOTOMICROGRAPH OF THE NORMAL ALBINO RAT
PLACENTA ON THE 20TH DAY OF GESTATION••••••••••••••••••••

55

A PHOTOGRAPHIC COMPARISON 01'., THE GROSS MORPHOLOGY OF
CONTROL AND HYDROXYUREA-TREATED 21 DAY FETUSES, •••••••••••

57

A PHOTOGRAPH OF A 20 DAY FETUS WITH MOST MARKED EVIDENCE
OF RESORPTION AFTER TREATMENT WITH HYDROXYUREA ••••••••••••

57

A PHOTOGRAPHIC COMPARISON OF CROSS SECTIONS OF CONTROL
AND HYDROXYUREA-TREATED FETUSES AT THE ~ORACIC LEVEL •• •·•.

59

PHOTOGRAPHIC COMPARISON OF SHAPES OF CONTROL AND
HYDROXYUREA-TREATED PLACENTAE IN GROUP! ••••••••••••••••••

61

A PHOTOGRAPHIC COMPARISON OF SHAPES OF CONTROL AND
HYDROXYUREA-TREATED PLACENTAE IN GROUP II.................

61

A PHOTOGRAPHIC COMPARISON OF SHAPES OF CONTROL AND
HYDROXYUREA-TREATED PLACENTAE OF GROUP III ••••••••.••••••••

61

A PHOTOGRAPHIC COMPARISON OF SHAPES OF CONTROL AND
HYDROXYUREA-TREATED PLACENTAE OF GROUP IV•••••••••••••••••

61

A

A HIGH POWER PHOTOMICROGRAPH OF LABYRINTH SHOWING
THICKENED PLACENTAL MEMBRANES AFTER TREATMENT WITH
HYDROXYUREA • •••••

10.

o • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •

A HIGH POWER PHOTOMICROGRAPH OF LABYRINTH SHOWING NORMAL
PLACENTAL MEMBRANES AJ:t""'Tlm TIU~ATMENT WITH THE VEHICLE OF
HYDROXYUREA • •••••••••••••••••••••••••••••••

11.

o • • • • • • • • • • • • • •

65

A HIGH POWER PHOTOMICROGRAPH OF LABYRINTH SHOWING NORMAL

PLACENTAL MEMBRANES AFTER 'fi?EATMENT WITH THE VEHICLE OF
HYDROXYUREA •••••••••.••· ••••••••••••••••••••••••••• • ••• • • • • •
13.

63

A HIGH POWER PHOTOMICROGRAPH OF LABYRINTH SHOWING
THICKENED PLACENTAL MEMBRANES AFTER TREATMENT WITH
HYDROXYUREA. • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • .. •

12,

63

65

A HIGH POWER PHOTOMICUOGRAPH OF LABYRINTH SHOWING
THICKENED PLACENTAL MEMBRANES AFTEU TREATMENT \YITH
HYDROXYUREA. • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • . • • •

vi

65

vii
Figure
Page
14. A HIGH POWER PHOTOMICROGRAPH OF A MITOTIC FIGURE IN A
TROPHOBLAST CELL OF LABYRINTH IN A CONTROL PLACENTA ON
18TH DAY OF GESTATION•••••••••••••••••••••••••••••••••o••• 67

15.

16.

17.

18 0

A HIGH POWER PHOTOMICROGRAPH OF A MITOTIC FIGURE IN AN
ENDODERMAL CELL OF VILLOUS YOLK SAC FROM CONTROL PLACENTA
ON 18TH DAY OF GESTATION••••••••••••••••••••••••••••••••••

67

A HIGH POWER PHOTOMICROGRAPH 01'"' THE VILLOUS YOLK SAC
PLACENTA ON THE 20TH DAY OF GESTATION SHOWING ABSENCE OF
IRON IN A CONTROL ANIMAL••••••••••••••••••••••••••••••••••

69

A HIGH POWER PHOTOMICIWGRAPH 01'"' THE VILLOUS YOLK SAC
PLACENTA ON '£HE 20TH DAY OF GESTATION SHOWING DEPOSITS
OF IRON AFTER TREATMENT WITH HYDROXYUREA ••••••••• o•••••O••

69

A HIGH POWER PHOTOMICROGRAPH OF GLYCOGEN-BEARING CELLS
IN SPONGY ZONE AFTER TRF...AT.MENT WITH THE VEHICLE OF
HYDROXYUREA • ••

19.
20.

21.
22.

o o ••••••••••••••••••••••••••••••• • ••••••• • • •

71

A HIGH POWER PHOTOMICROGRAPH OF GLYCOGEN-BEARING CELLS
IN SPONGY ZONE AFTER TREATMENT WITH HYDROXYUREA••••••••o••

71

A HIGH POWER PHOTOMICROGRAPH OF GLYCOGEN-BEARING CELLS
IN SPONGY ZONE AFTER TREATMENT \VITH THE VEHICLE OF
HYDROXYUREA •••••• •·• • •••••••••••••••••••• • ••••••••••••••• • •

71

A HIGH POWER PHOTOMICROGRAPH OF GLYCOGEN-BEARING CELLS
AFTER TREATMENT WITH HYDROXYUREA•••••••••••••••••••••••••o

71

A HIGH POWER PHOTOMICROGRAPH OF PLACENTAL LABYRINTH
SHOWING STROMAL CALCIFICATION ASSOCIATED WITH A DEAD
FETUS AFTER TREATMENT WITH HYDROXYUREA••••••••••••••••••••

73

r
ABSTRACT
This thesis is concerned with the effects of an anticancer agent,
Hydroxyurea, on the developing albino rat conceptus and in particular
the placenta.

Hydroxyurca, besides being an active chemotheraputic

agent, is also a teratogen affecting rapidly growing and developing
embryonic tissues.
Hydroxyurea, dissolved in boiled, distilled water, was administered intraperitoneally on 2 occassions at 3 day intervals, during
the latter third of gestation to four groups of pregnant animals which
were divided on the basis of dosage and time of injection.

The groups

were injected respectively on the 14th and 17th (I), 15th and 18th (II),
and 17th and 20th days (IV), with 2000mg/Kg of hydroxyurea.
was injected with 2500mg/Kg on the 16th and 19th days.

Group III

Necropsy ot

groups I, II, III, and IV occurred on the 18th, 20th, 20th, and 21st
days respectively.
Experimental animals showed a weight gain from the first day of
injection until necropsy that was approximately only half that observed
in control rats.

Fetuses were weighed, measured, fixed in 3 formalin

fixatives and subsequently examined for malformations.

It was observed

tJ.hat the average weight and length of experimental fetuses was smaller
than controls but both were within normal limits ot development.

Mal-

formations in experimental. fetuses included underdeveloped ear flaps
and vibrissae, short, stubby limbs and snout, enlarged shoulder and
upper thoracic region, edematous trunk, and unwrinkled stretched skin.
viii

ix
The edematous appearance was caused by extensive accumulations of fluid
especially under the skin and secondarily in the body cavity.
Placentae from non-treated and hydroxyurea-treated rats were
examined by means of the following techniques: Hematoxylin and Eosin
for general morphology; Periodic acid-Schiff method for glycogen plus
diastase-Alcian-Blue treated controls for mucopolysaccharides and acid
mucopolysaccharides; Gomori's modification of Perls' method for iron;
0.06% toluidine blue for the metachromasia and basophilia; and the
Glyoxal Bis (2 hydroxyanil) method for calcium.
Placentae from experimental animals lost their button-like shape
and appeared flattened and shaped more like a shallow cup but the diameter of these placentae was found to be similar to those of controls.
The width of the labyrinth of experimental placentae was smaller while
the width of the spongy zone varied little from that of control specimens.

It appeared that the decreased width of the labyrinth may have

been caused by a pulling together (retraction) of the vascular tree and
its accompanying stromal tissue.

Stromal cells were brought closer

together and gave the appearance of an increase in the number of these
cells present in the labyrinth.

Thickened labyrinthine plates and

roughened irregular face of the maternal sinuses are believed to be a
consequence of the vascular tree retraction.

Since hydroxyurea acts

mainly on dividing cells, and since these changes occurred after cell
division is supposed to have ceased in the placenta, the mode ot action
of the drug is not yet fully known.

However, occassional mitoses were

observed in the trophoblastic and.mesodermal cells of the labyrinth and

x

in the endodermal cells of the villous yolk sac.
Iron, in the form of ferric ferrocyanide deposits was observed in
increased intensities in the endodermal cells of the villous yolk sac
and in the connective tissue stroma and trophoblastic cells of the labyrinth and in the cells of the decidua basalis in experimental specimens.

Placentae :from control, non-treated rats, contained almost no

evidence of iron deposits in any of these areas.
Glycogen deposits in hydroxyurea-treated placentae showed no variation from those of control placentae.

However, the amount of neutral

mucopolysaccharides present in the labyrinth was greater inecperimental
than in control placentae.
Increased evidence of insoluble calcium deposits in the placenta
was observed in hydroxyurea-treated rats from all four groups while
those of controls were almost entirely free of calcium.

Calcium and

iron are both cations which can be bound to polyanionic substances like
mucopolysaccharides.

Staining by toluidine blue for these

ac~d

stances was too variable to allow for an accurate evaluation.

subHowever,

it appears likely that increased amounts of acid compounds were present
in the experimentals.
In part of group III the fetuses were dead at maternal riecropsy.
In these placentae greater intensities of iron, calcium, and granular
basophilic accumulations

w~re

observed. than in other experimentals.

It

appears likely that .fetal distress or feta-placental dissociation
(Emmert, '57) played the major role in bringing about the histochemical
changes that occurred.

INTRODUCTION

It is l<...nown that cancers occur during pregnancy and in some
instances are treated by chemotherapy (Sokal and Lessman, '60),

--

(Hutchison, et al., '68), (Armstrong, et al., '64).

-

We are concerned

with the effects which anticancer agents have on the developing conceptus and in particular the placenta.

Hydroxyurea (HU) is an active

chemotheraputic agent with inhibitory and teratogenic effects on rapidly
growing and developing tissues.

First synthesized in 1869, it has been

shown to be a colorless, weakly acidic, crystalline solid with a melting
point of

14o0 c.

It has a molecular weight of 76 and a chemical config-

uration of IIO-HN-CO-NH 2 •

It is known to inhibit experimental tumors in

mice (Stearns, Losee, and Bernstein, '63) and to be active against
chronic granulocytic leukemia.

Recent evidence indicates that it .is

inconsistently active against other malignant neoplasms in man (Krakoff,
Murphy, and Savel, '63), (Lerner and Beckloff,

1

65), (Thurman, Bloedow,

Howe, Levin, Davis, Lane, Sullivan, and Griffith, '65).

In the mouse,

it inhibits sarcomas, carcinomas, and leukemias.
Hydroxyurea has been given orally, intravenously, intraperitoneally
and subcutaneously and was determined to be toxic to the host, its
tumor(s) and conceptuses by all such routes (Wilson and Warkany,
In addition, HU produced

~eurotoxic

1

65).

effects such as anesthesia and/or

excitation (Wilson and Warkany, '65).
Hydroxyurea has been observed to inhibit DNA synthesis but not RNA
1

2

or protein synthesis in cultured mammalian cells (Young and Hodas, '64),
in regenerating rat liver (Schwartz, Garofalo, Sternberg, and Philips,
'65) and in bacteria (Gale, Kendall, McLain, and DuBois, '64), (Rosenkranz, Garro, Levy, and Carr, '66), (Krakoff, Brown, and Reichard,

1

68).

The teratogenicity of any drug is subject to a complex number ot
parameters.

For a drug to cause disturbances in embryonic development

it must be given at the proper dose, to a suitable species at a specific
stage of embryonic development.

This specific stage of development can

induce a discriminating sensitiveness at the level of molecules, cells,
tissues, and organs in both a quantitative and qualitative interpretation.

The rate at which the pregnant animal and conceptus detoxifies

and excretes the drug is variable depending upon the routes and frequencies of administration.

Nutrition is important and yet other undis-

covered constituents probably alters responses to drugs.
-·

A typical test for determining the teratogenicity of a drug in
embryonic rats is to administer an initial dose that is the acute LD
50
for mature rats.

The LD

50

for mature non-pregnant rats is 4.7mg/Kg.

Pregnant rats in the 9th to 12th days of gestation are given this dose.
Fetuses are then examined at term (21 days) for signs of life, resorption, and normalcy.

If the young are alive and appear normal the drug

is not considered teratogenic (Wilson and Warkany, '65).
Conceptuses, like tumor cells, manifest actively growing components
Few investigators have observed the teratogenic effects ot single and
multiple doses of HU on the conceptuses or experimental animals.
( 1

Gaik

67) recorded the effect of single doses of the drug on the albino

3

fetus and placenta.

At doses ranging between 300mg/Kg and 2500mg/Kg

pregnant rats were injected between the 9th and 19th days of gestation
and necropsied between the 15th and 20th days.

The results varied with

the magnitude of the dose and the day of administration.

Weight loss

was observed in the pregnant rat and fetuses were resorbed or retarded
in growth or presented developmental abnormalities.
examined histologically and histochemically.

Placentae were

Increased calcium and

iron deposits and decreased glycogen intensities over control placentae
were demonstrated.

In two instances a second dose of HU was injected

three days after the first injection.

In the first instance the in-

jections were given on the 14th and 17th duys and in the second instance
on the 16th and 19th days of gestation.
eloped.

Abnormally large fetuse_s dev-

Their gross structural development

appeared edematous almost

like a swollen "stuffed sausage" and their snout and limbs were abbreviated and stumpy respectively.

In this thesis the object is to observe the effect of multiple,
subrethal doses of HU on conceptuses when injected into pregnant albino
rats.

REVIEW OF LITERATURE

..
The structure and function of the placenta has for centuries
intrigued investigators.

A lack of understanding of its fine structural

anatomy and physiology, however, has contributed to the many and varied
philosophic and scientific theories and interpretations that occur in
the literature.
Galen in 300 AD described in detail the human chorion, its blood
sunply and its relationship to the uterus (Brock,

1

28).

Realdo Columbus

in 1559 (cited by Krantz, '58} was credited with naming the organ the
placenta because of the shape of the human organ.
Fabricius, in the 16th century, described· the human placenta as a
fleshy mass that clings very closely to the uterus and is thoroughly;
interwoven with the minute ends of the umbilical vein and artery.

He·

considered its position only as a "convenience" for the umbilical vessels and that the blood flow between the uterus and fetus was continuous
Krantz ( 1 58) reviewed the con.tributions of William Harvey who in
1653 believed in the separateness of maternal and fetal circulations
when he observed differences in maternal and fetal heart rates.

He

proposed that the placenta functioned in providing nutriment for the
embryo.
Today, the placenta, ·Of mammals, is considered as a temporary organ
of fetal and maternal tissue lying in close apposition for the purpose
of physiological exchange of substances between maternal and fetal blood
streams.

4

5

Mathias Duval (1891) was one of the first investigators to describe
the morphology of the rat placenta in great and accurate detail.
Grosser ( 1 27) summarized comparative placentation and was the first
to propose that placentae be classified as to the number of layers
between maternal and fetal blood streams.

As a common denomenator for

classifying types of placentae he used the name of the maternal tissue
that was in closest association with the chorion.
Mossman ( 1 37) with slight modifications extended Grosser's work
with the addition of more species and brought it up to date.

He dis-

covered in the rabbit that near term the syncytial membranes between
the two blood streams disappear creating a hemoendothelial condition
and suggested that other rodents, such as the rat and guinea pig also
be classified in a separate hemoendothelial group.
However, Hard ('46), Wislocki, Deane, and Dempsey ( 1 46), and
Bridgeman ( 1 48) in the rodent, and Wislocki and Bennet ( 1 43) in human
and monkey placentae described a syncytial layer which persists to
term.

Wislocki, Deane, and Dempsey ( 1 46) described in some areas of

the labyrinth silver staining fibers surrounding the fetal capillaries
at term.
Amoroso ( 1 61), using the light microscope, described the hemochorial placenta as initially composed of cytotrophoblast which later
becomes ayncytiotrophoblast.

Separating this layer from the fetal blood

vessels were fine collagenous or reticular fibers.

These decrease as

gestation advances and by term only a very thin layer of syncytium
separates fetal endothelium and maternal blood.

6

Ultrastructurally, the rat placenta consists of four layers of
tissue separating the maternal and fetal blood streams (Jollie '64a).
From the maternal to fetal side it includes trophoblast I and trophoblast II which are cellular; element I I I which is syncytial and rich in
lipids; and finally, IV, the fetal·endothelium with its basement membrane.
The placenta is a comparably vigorous organ, more resistant to
delaterious influences than the fetus.

The fetus can be damnged or

suffer severe, critical distress in utero while the placenta and fetal
membranes will often show little or no signs of gross alteration.

How-

ever, there is a mounting body of literature which indicates that there
are profound microscopic changes which develop in the absence of a
living fetus as will be considered below.
Changes that occur in the uterus and placenta depend upon the condition of the embryo, whether alive or dead; on the method of aborting
or injuring, mechanical or chemical; and lastly on the time in gestation
at which the stress was inflicted.
Pritchard and Huggett ('47) surgically removed or mechanically
crushed Norwegian rat fetuses on the 10th through 19th days, and
observed subsequent placental development.

~hen

Placentae of fetuses removed

on the 10th day showed pronounced resorption of the omphalopleure,
allantoic mesoderm and its fetal vessels and the neighboring labyrinth
by the 14th day.

The rest of the labyrinth and spongy zone grew until

the 16th day when further growth ceased.

Normal trophoblastic differen-

tiation occurred but the placentae were spherical and subnormal in size.

7

Degenerative changes began to predominate; giant cell and spongy zones
became destroyed by hemorrhages and thromboses.
the trophoblastic syncytium remained healthy.

By the 19th day only
Placentae from fetuses

removed on the 13th and 14th days were well vascularized by allantoic
vessels, the connective tissue of which persisted to term around the
clumped remains of the large fetal vessels.

The shape of the placentae

was discoid but the placentae were smaller in size.

Placentae of fetuse

removed after the 16th day differed somewhat from the above.

Residual

omphalopleure and entodermal sinuses of Duval and the giant cell and
spongy zones remained normal but in the labyrinth degenerative changes
occurred which differed from the above.

Endothelial nuclei of collapsed

fetal vessels did not clump up or round up but remained elongated and
in linear appearance.

A thick layer of exudate containing maternal RBCs

and fibrin strands accumulated around these collapsed vessels, and in
some places obliterated maternal blood channels causing local necrosis
of the labyrinth.
Henderson ('54) found that after surgically terminating further
development of rabbit embryos, in

~'

on days 11, 16, or 19 post

coitum the placentae were slow to show any changes.

At necropsy, preg-

nant females which were previously treated by a subcutaneous administration of 5mg of stilboestrol in olive oil on the 11, 16, or 19th days
had deciduae and placentae which showed signs of degeneration before the
embryo.
Emmert ('57) performed mechanical feto-placental dissociation on
cotton rats on the 15th, 20th, and 25th days of

a 27 day gestation
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period.

Subsequent examination six hours to five days after operation

showed rapid degenerative changes in amnion and yolk sac and slower
deterioration of the chorionic trophoblast.

The placental changes

observed developed more rapidly the nearer to term dissociation occurred,
These changes included at first small foci followed by a general· infil:..
tration of the stroma of the labyrinth by a granular basophilic material
accompanied by deposits of calcium, iron and phosphate.

These stromal

alterations did not develop in the absence of maternal blood flow
through the placenta.

The trophoblast swelled and blistered away from

the supporting connective tissue and· occluded maternal blood channels
causing ischemic degenerative

change~

(necrosis) in the spongy zone and

decidua basalis as well as in the labyrinth.
Payne ( 1 58) produced changes in the rat placenta and fetus after
infection with different species of bacteria by intraperitoneal injectioJ
on the 13th day of gestation.

Payne observed that the periplncental

uterine wall manifested signs of ulceration and inflammatory reaction.
The mesometrial surface of the placental disc became ulcerated and
large accumulations of organisms, eroded cells, and debris occurred' at
the angle of the yolk sac wall and disc.

The yolk sac endothelial cells

adhering to Reichert's membrane proliferated to two to three cell layers
thick in response to this accumulation of organisms and formed a barrier
With very severe infections this barrier lost its integrity, organisms
penetrated the sinuses of Duval deep in the labyrinth and formed abscesses.

Necrosis and abscess of the visceral yolk sac wall followed

by invasion of the amniotic cavity and infection of the fetal respirator.

9

tract· were caused by group£•

~~reptococcus

and£•

R~ogenes.

The teratogenic effects of HU were studied by Bendich, Ilorenfreund,
Korngold, and Krim ('63) who reported that HU, hydroxylamine, and
several other drugs caused chromosomal breaks in phage DNA in cultured
mammalian cells and in mouse embryo cell cultures after an exposure
time of 48 hours.
}.turphy and Chaube ( '64) found HU to be teratogenic for the rat,
chick, and sand dollar embryonic systems.

The pregnant rats were

administered 50-2000mg/Kg of HU on the ninth to 12th days of gestation
and killed at 21 days.

Growth was retarded; hairlip, cleft palate,

encephaly, retarded clubbed fore and rear appendages and a retarded
tail were found.

Volumes up to 0.2 ml of 0.1-0.Smg/egg of HU in saline

were injected into four day old chick embryos and inspected as they
died or were necropsied at 18 days.
mality observed.

Beak defects were the only abnor-

In the treated sand dollar embryos normal development

was observed from fertilization until early morula stage at which time
development was blocked.

The sea urchin embryos showed extensive

chromosomal aberrations which included nuclear enlargement, elongation
of rnetaphase chromosomes, anaphase bridging, fragmentation of chromosomes, polyploidy, and some C-mitoses (mitoses arrested in metaphase).
Gale, Kendall, McLain, and DuBois ('64.) observed that when HU was
added in a concentration o.f l .0-1. 6mg/ml to the culture medium of Pseudo
monas

aeruginos~

in the early log phase of its growth cycle and then

incubated for 18 hours, marked elongations

up

to 30 times the normal
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length of 2.5 micra occurred.

Electron microscope studies revealed

that the gross morphology of both experimental and control specimens
differed only in their length.

-nosa

Inside the treated Pseudomonas

aerug~-

the amount of nuclear material was diminished or absent and the

cytoplasm was more granular than in controls.

In 1966 Gale observed

the effects of oxymal hydroxyamic, a derivative of
negative bacteria Escherichea

£21!.•

nu,

on the gram-

Again the gross morphologic change

elicited was the enhanced length of the treated cells.

This time the

increase was far greater than for Pseudomonas aeruginosa.
Ferm ('65) injected pregnant hamsters on the eighth day of gestation with a single i.v. dose of 50mg HU in saline solution.
were removed and examined on the ninth or 11th days.

Fetuses

The congenital

malformations observed, in addition to the above exencephaly, included
abnormally coiled cardiac tubes and a failure of the neural tube to
close.
Sinclair ('67) observed that when cells of the Chinese hamster,
grown !,,!! vitro, were exposed to l.OmM HU for 1.2 hours only those cells
in the DNA replication or synthesis (S) phase of the cell cycle failed
to divide.

These cells did resynthesize DNA after drug removal, enlarge

three to four times their normal volume in the next 20-30 hours, and
then lysed.
There are several the.ories regarding the mechanis111 by which HU
inhibits DNA synthesis.

The one having the most proponents holds that

HU blocks DNA synthesis at the conversion of 'molecules of ribotides to
desoxyribotides.

Included in this group are Mohler ('64), Young and

11'

Hodas.( 1 64), Frenkel, Skinner, and Smiley ('64), Schwartz, Garofalo,
Sternberg, and Philips ( 1 65), Frenkel and Arthur ('67), Young, Schocketman, and Karnofsky ( 1 67), and Krakoff, Brown, and Reichard ('68).

A

disparity exists in the literature between those favoring this mechanism
of action for HU and the interpretations of Yarbro ('68) and Pollak and
Rosenkranz ('67).
Yarbro ('68) studied the effects of the four exogenously administered desoxyribonucleosides and ribonucleosides on the incorporation

of 32 p into DNA and RNA in the mouse ascites tumor both in vitro and in
vivo.

32
P

The four desoxyribonucleosides stimulated incorporation of

into DNA aud depressed incorporation into RNA.

The four ribonucleo-

sides promoted incorporation into both DNA and RNA.
HU prevented the promotion of
nucleosides.

He observed that

32
P incorporation into DNA by the ribo-

No effect was observed on incorporation into RNA.

Yarbro

believed that if the above theory regarding the mode of action of HU
were valid then addition of the desoxyribonucleosides would overcome
the HU-induced inhibition.

He reasoned that some other mechanism was

responsible for the inhibition.
Pollak and Rosenkranz ('67) similarly believed that adding a desoxyribonucleoside should overcome the inhibition and DNA synthesis
could resume.

However, they found that HU interference with DNA metabo-

lism of

cells transformed by polyoma virus was not reversed by

~HK-21

the addition of radioactive desoxyribonucleoside.
On the other hand Fishbein and Carbone ( 1 63) proposed that HU split
into hydroxylamine which reacts with Acetyl coenzyme A, cleaving it and
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thereby causing a decrease in oxidative phosphorylation with a concomitant lowering ot ATP.

Gale, Kendall, McLain and DuBois ('64) agree with

this mechanism of action.
Vogler ( 1 66) presented evidence which suggested that HU may act
early in DNA

synthesis by blocking the

~ ~

synthesis of pyrimidine.

Vogler administered 6-azauridine to six cancer patients.

This compound

is known to specifically inhibit the enzyme, ortidylic decarboxylase
resulting in a marked increase in the urinary excretion ot orotic acid
and orotidine.

Orotic acid is the precursor of pyrimidine.

HU in

a,

dose of 40-45mg/Kg per day was administered tor five days and reversed
the orotic acidurea.

MATERIALS AND METHODS
Twenty five sperm-positive female albino rats

l

were housed two per

cage and given water and Rockland rat food ad libitum.
5,7, and 25 were not pregnant at necropsy.

Rats numbered

Four rats numbered l, 2, 3,

and 4 were necropsied on the 13th, 15th, 16th, arid 20th days of gestation, respectively, and their placentae were fixed, sectioned, stained
with Hematoxylin and Eosin and Periodic acid-Schiff (PAS) and examined
histologically as a preliminary j)rocedure.

Animals numbered 1, 2, and

3 were not included in this stucly and animal No. 4 was used as an
auxiliary control.

During the latter third of gestation the remaining

18 rats were anesthetized with ether on two occassions at three day
intervals and given an intraperitoneal injection of HU dissolved in
boiled distilled water on each occassion.
The rats were placed in four groups on the basis of dosage and
time of intraperitoneal injection (Table I).

Group I was injected on

the 14th and 17th days of gestation with 2000mg/Kg of HU and was necropsied on the 18th day.

Group II was injected with 2000mg/Kg of HU on the

15th and 18th days and necropsied on the 20th day.

Group III was

injected on the 16th and 19th days with 2500mg/Kg of HU and necropsied
on the 20th day.

Group IV was injected with 2000mg/Kg on· the 17th and

20th days and necropsied on the 21st day.

The rats were weighed just

prior to each injection and again just before necropsy following an
1. Hormone Assay Inc., Chicago, Illinois
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overdose of nembutal administered intraperitoneally (Table I).
The body wall of each rat was shaved, opened and the uterine horns
with their intact conceptuses were removed and immediately placed in a
.

physiological saline solution heated to 37

0

c.

Each fetus with its

placenta was excised individually from the uterus.

The two were sepa-

rated and the fetus was examined for signs of life (heart beat and
respiration), weighed, and measured (crown-rump length) (Tables II,III).
Fetuses and placentae were then fixed in Baker•s

2

calcium formalin,

alcohol formalin 3 , or pyrognllol formalin (Husby, '46).

Fetuses were

subsequently examined under the dissecting microscope for malformations.
The placentae were dehydrated, embedded in paraffin, and sectioned at 6
micra.

The following staining techniques were used to study the placen-

tae: 1) Hematoxylin and Eosin

4

for general morphology; 2) PAS

glycogen; Alcian Blue-PAS-Diastase (Mowry,

1

7

for

63) was used for the control

slides for PAS; 3) DNA was demonstrated by the Feulgen
method modified by Gomori

5

6

method; 4) Perls

was used to demonstrate ferric iron in the

tissues; 5) Calcium was demonstrated by the Glyoxal Bis (2 hydroxyanil),
GBHA,

metho~

(Kashiwa and House, '64); 6) Metachromasia and basophilia

were demonstrated by 0.06% toluidine blue buffered to pH 3.5.
The weight and length of the fetuses were compared to the stages
of Christie ( 1 64) so as to determine whether or not these animals were

2.
3.
4.

5.
6.
7.

Lillie,
Lillie,
Lillie,
Lillie,
Lillie,
Lillie,

( 1 65), P• 293.
cit. P• 42.
cit. P• 176.
cit. p. 198.
cit. P• 149.
op. cit. PP• 405-406.

R.D.
op.
op.
op.
op.

15

within normal limits proposed by Christie.
Due to limited circumstances the control animals from group II
were necropsied 48 hours after the second injection and not 24 hours
as was performed on groups I, II, and IV.

RESULTS
The number of animals in each experimental group, the dosage, and
days of treatment and necropsy together with the weight of the animals
at each injection and at necropsy is contained in Table I.
Maternal Wei5hts
In each group the non-treated control animals showed a steady
weight increase after receiving injections of boiled distilled water,
!.·~!'

the vehicle for

HU~

Control animals from group I showed a weight

increase of nearly 60 grams from the first injection until necropsy.
Experimental animals showed a weight increase of only 27 grams after
receiving two injections of HU until necropsy.
Similar to the weight gain of control animals in group I, group II
controls showed an increase of more than double that of experimental
rats.

Although experimental animal No. 8 had a weight loss after the

first injection, it recovered to a level j_ust above its pre·existing
weight when necropsy occurred (Table I).
The animals in group III, Nos. 9, 10 1 11, and 12 were treated in
the old Anatomy animal quarters at 706
the fetuses were dead at necropsy.
were treated

at 1400

s.

s.

Wolcott Avenue in Chicago and

Animals Nos. 21, 22, 23, and 24

First Avenue, Hines, Illinois.

The first set

of experimental animals in group III showed a weight gain of approximately 50% that of control No. 21 while the second set showed a ·.weight
increase of over 90% that of the control.
The weight gain in control animal No. 17 of group IV was more
16

17
than double that of experimental animals Nos. 18 and 19.
Fetal Weight

~

Length

The number and condition of fetuses recovered at necropsy following
treatment with HU is contained in Table II.

The 19 pregnant females

produced 200 conceptuses with an average of 10.8 conceptuses per animal.
Fetuses from all four groups were alive at necropsy except for the
following: in group I, animal No. 16 contained one dead fetus which
appeared normal; in group III, animals Nos. 9, 10, 11, and 12 contained
fetuses which were all dead of which two from No. 10 showed evidence of
resorption; while animal No. 23 contained one dead, resorbed fetus.
The most extensive evidence of resorption was observed in this fetus
No. 23R, injected on the 16th and 19th days and necropsied on the 20th
day of gestation.

Figure 3 illustrates the extent of resorption.

The weight and crown-rump length ot fetuses for both experimental
and control specimens in all four groups were within the normal limits
of development proposed by Christie ('64) (Table III).

However, in all

groups the control fetuses were larger than experimental fetuses in
both measurements. In group III the dead fetuses from animals Nos. 9 9
10, 11 9 and 12 were slightly smaller in both weight and'

~ength

than

those from animals Nos. 22, 23, and 24 which were alive at necropsy.
Fetal Morpholo!l
Aft~r

microscope.

fixation the

were examined under the dissecting
.
.
.
In group I the control fetuses showed that vibrissae had
f~tuses

developed, digits on fore and rear paws were separated, eyelids were
sealed, ear flaps were present and the umbilical hernia was reduced.
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Experimental specimens contained less developed vibrissae, limbs were
shorter and appeared stumpy and the digits were not as well developed
as in controls.

In addition the fetuses appeared very edematous with

skin stretched very thin and easily crumbled to the touch.

An enlarged

umbilical hernia was not present.
The control fetuses of the second group of rats had sealed eyelids,
well-developed ear flaps, nails, pads on the paws and vibrissae and no
umbilical herniation.

Under close examination, the experimentals bad

ear flaps that were underdeveloped; skin was stretched; the trunk was
edematous; the snout appeared short and stubby and the limbs were also
short·.

The chest cavity was enlarged over the heart and no

umbilical~

hernia was present (Figure 2).
The controls and experimentals in group III were similar in all
respects to those of group II.

These fetuses were further examined by

removing the head, with a scapel, just anterior to the fore limbs.

A

large quantity of fluid was accumulated in the body cavities around the
viscera and just beneath the skin of the experimental animals.

No

gross changes in the viscera were observed (Figure 4)·.
The animals in group IV were also similar in characteristics to
those in group II.
Placentae
From a total of 200 placentae from 19 rats, 151 placentae were
examined histologically and histochemically.
The definitive placenta of the rat is clcissif'ied as discoidal,
hemochorial, labyrinthine and chorioallantoic.

Formation of the
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placenta begins at the mesometrial pole of the blastocyst where there
is a proliferation of ectoderm (trophoblast) to form the ectoplacental
cone.

This proliferation is the precursor of the fetal portion of the

placenta and begins its development on the sixth day.

On the seventh

day of gestation, the developing blastocyst implants eccentrically in
an antimesometrial crypt of the uterus.

A decidual reaction in the

uterine tissue surrounding the blastocyst obliterates the uterine lumen.
On the aeventh day the ectoplacental cone begins invading and
destroying uterine tissue and the endothelial lining of the maternal
blood vessels.

Blood is extravasated, becomes surrounded by tropho-

blastic tissue which forms sinuses.
An important area of exchange for the embryo is the inverted yolk
sac or vitelline placenta which is developing from the seventh to
eleventh days of gestation.

The yolk sac placenta is divided into two

morphologic zones: (1) an outer,non-vascular, parietal _wall consisting
of scattered endodermal cells which incompletely line the interior surface of Reichert's membrane (N.B.: Reichert's membrane is a_thick basement membrane which adheres externally to trophoblastic giant cells),
and (2) an inner, vascularized, visceral wall composed ot endodermal
cells adjacent to a mesenchymal layer in which are embedded the vite1line blood vessels.
By approximately the .13th day of gestation a cleft appears antimesometrially to

th~

embryo.

This cleft, which is continuous with the

uterine lumen divides the decidual mass into a capsularis in contact
with the developing conceptus and a decidua parietalis lining the
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uterine wall. By the 14th day, the remaining decidua capsularis has
degenerated along with the parietal wall ot the yolk sac, including
Reichert's membrane together with any residual trophoblast.

This

results in the exposure of the endoderm of the visceral wall of the yolk
sac to the uterine epithelium for the purpose ot exchange.

The parietal

yolk sac is retained as a covering for the fetal aspect ot the chorioallantoic placenta and extends inward into the placenta as double-walled
sleeves around large fetal vessels entering and leaving the placenta
(the endodermal sinuses of Duval).
The mesodermal allantoic process has been growing across the exocoelom toward the base of the ectoplacental cone and on the 11th day
reaches the chorionic mesoderm fusing with it.

This vascular chorio-

allantoic mesoderm now projects at intervals into the ever expanding
trophoblastic villi of the cone forming trophoblastic lamellae.

The

definitive chorioallantoic placenta is now formed and continues to grow
and expand until term.
Three general zones7are recognized in the chorioallantoic placenta:
(1) the outermost layer consists of phagocytic giant cells of trophoblastic origin; the area of the endometrium adjacent to this area is
known as the decidua basalis; (2) under the giant cell zone is a spongio·
trophoblastic or spongy zone containing only maternal sinusoids which
are surrounded by sheets

~f

oval or polyhedral cells and clusters of

polyhedral cells storing glycogen; (3) this zone partially surrounds
the labyrinth which is composed of an intricate branching network of
plates of fetal tissue; these plates have a mesodermal core containing
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the fetal capillaries and are covered by trophoblast.
circulates in the spaces between adjacent plates.

Maternal blood

It is in this area

that most of the physiologic exchange occurs.
The maternal and fetal circulations now lie very close to one another and are separated only by the four electronmicroscopically discernible layers of trophoblast and fetal endothelium.
Fetal capillaries in this zone are small, round, lined by a layer
of endothelium, and most often contain immature red blood cells.
Maternal sinuses are generally larger than fetal capillaries and are
irregular in outline and contain only mature red blood corpuscles.
Placental J.Iorphologl
When sections from the_region of the central axis of the placentae
were examined the shapes of control placentae were disc- or button-like
while those of experimentals were flattened and more cup-shaped giving
the appearance of having a greater diameter (Figures 4,5,6,7).

However,

when the diameters of the placentae were measured, in millimeters by
means of a plastic ruler overlying the specimen, they were found to be
similar in both control and experimental animals for all foun groups
(Table IV).

The average diameter or experimental placentae from all

four groups ranged from 9.0-11.0 mm. and from 9.6-11.6 mm. for controls.
In group III, experimental placentae Nos. 9, 10, 11, and 12 carrying
dead fetuses at necropsy averaged 10.0 mm. and the remaining group III
specimens which carried live fetuses at necropsy averaged 11.8 mm.
Micrometer measurements of the width of the labyrinth and spongy
zone taken at approximately mid-placenta were also obtained in
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millimeters at 40X magnification (Table V).

In each group the width

of the labyrinth in the experimental specimens was smaller than in
controls.

In group I, the control labyrinths averaged 2.26 mm. while

experimental labyrinths averaged 1.63 mm.

In group II, the average of

the controls was 2.38 mm. and that of experimentals was 2.15 mm.

The

control labyrinths of group III averaged 2.30 mm. and those of experimentals 1.99 mm.

The widths of the labyrinths of Nos. 9, 10 9 ll, and

12 of this group were only slightly smaller than the rest of the experimental placentae in the group.

In both experimental and control placen-

tae the width of the labyrinth increased from groups I to IV.

The

widths of the spongy zone in control placentae varied little from the
experimentals in groups I, III, and IV.

In group II, the spongy zone

of treated placentae was more than 30% larger than non-treated specimens
In gr·oup I, the average widths of experimentals and controls for the
spongy zone were 0.75 and o.74 mm. respectively.

In group II, the

control average was o.48 while the experimental average was 0.70 mm.
In group III, experimental and control averages for the spongy zone
was o.54 and o.57 mm.respectively.

In group IV, the experimentals ave-

raged 0.42 and the controls averaged 0.50 mm.

In both treated and non-

treated specimens,the width of the spongy zone decreased with advancing
age,

~·~·

the width was largest in group I necropsied on the 18th day

and smallest in group IV necropsied on the 21st day.

This decrease is

consistent with a loss of glycogen cells from this zone.
The number of trophoblast cells ih the labyrinth of the placentae
of experimental animals in all four groups appeared to be less than
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those of the controls.

Trophoblast cell nuclei were similar in size

to those in control placentae but were spaced farther apart.

In addi-

tion the membranes or trophoblastic plates between fetal and maternal
blood channels appeared to be thicker and to present a more irregular
surface facing the maternal blood spaces than in control placentae
(Figures 9,10,11,12,13).

The fetal capillary endothelium was often

separated from its mesodermal stroma and wholly or partially collapsed
in experimental placentae.

This occurred less often in control placen-

tae.
Trace amounts of local basophilic accumulations were observed in
the connective tissue of all four groups.
The following was observed concerning the quantity of blood cells
in maternal and fetal blood channels in both experimental and control
placentae: 1) the maternal sinuses in the labyrinth tended to contain
more formed elements of the blood than did the fetal capillaries; and
2) as the mnter of the labyrinth was

~pproached

less and less blood

was observed in both channels; the periphery of the placenta was observed to contain a more uniform quantity of blood in its sinuses.
In all groups, the cell size in the giant cell zone, spongy zone,
and yolk sac placenta appeared similar as did the shape and arrangement
of cellsin both the treated and non-treated specimens.
Specimens examined fo'r nuclear detail with the Feulgen stain
showed results similar to those found after staining with Hematoxylin
and Eosin.

Connective tissue nuclei appeared to be closer together and

trophoblast cells in the labyrinth of experimental specimens appeared
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to be spaced farther apart than in control placentae.

In addition

mitotic figures were observed in some trophoblastic cells of the labyrinth and endodermal cells of the villous yolk sac in each group (Figures 14,15).
Iron
In all specimens examined the bluish-green colored ferric ferrocyanide (iron) deposits (ID) were present in the spongy zone and in the
giant cell zone.

In control specimens of all four groups, iron deposits

were not observed in the yolk sac villous cells while experimental
specimens contained moderate to substantial intensities (Table VI) (Figures 16,17).
The intensity of iron present in the placentae varied with the
fixative.

In all groups, the calcium formalin fixed specimens contained

the most iron; alcohol formalin fixed placentae displayed a lesser
intensity.

Unfortunately, pyrogallol formalin fixed specimens proved

histotechnically inferior for assessment.

Only calcium and alcohol

formalin fixed specimens were utilized in this determination.

In all

four groups, iron deposits in the labyrinth and decidua basalis were
varied in their intensities.
In group I, moderate intensities of iron were

observ~d

in the con-

nective tissue stroma and trophoblast cells of the labyrinth of ten
experimental specimens, a trace amount in three and none in two specimens.

All the.control specimens were devoid of iron.

basalis, barely

perc~ptible

In the decidua

deposits were observed in three experimental

placentae and none in the remaining 12 specimens or in the controls.
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The decidua basalis in two control and nine experimental placentae
of group II contained faint traces of iron, while none was observed in
eight control and two experimental specimens.

The labyrinth of three

placentae showed trace intensities of the blue ferric iron accumulations
while eight experimental specimens contained trace to moderate amounts.
In the remaining treated and non-treated specimens iron deposits were
not observed.
Control placentae in group III did not contain iron deposits.
Similarly in nine experimentals iron was absent.

In 11 experimentals,

trace intensities presented• and in nine specimens moderate to substantial deposits were observed.

The decidua basalis in this group, in

experimentals and controls, appeared essentially negative for iron.
In group IV, two control placentae contained trace intensities and
one control contained substantial deposits of iron.
sent in the three remaining control placentae.

Iron was not P.re-

In seven experimental

placentae, small barely perceptible deposits were observed.

In the

decidua basalis, trace intensities of iron were observed in-three controls and in all experimentals.

The remaining controls did not contain

iron.
Glycogen
There was much similarity of results obtained for the presence ot
glycogen· in both experimental and control placentae fixed in calcium
formalin and alcohol formalin throughout the four experimental groups.
In the decidua basalis trace intensities of glycogen were observed in
those cells which had not started to undergo degeneration.

Cells in
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different stages of degeneration appeared to contain greater deposits
of mucopolysaccharides.

The connective tissue around each giant cell

in the giant cell zone appeared to contain traces of glycogen, while
none was observed in the giant cells themselves.

Glycogen in the form

of tiny granular deposits was observed in the connective tissue and
trophoblast cells of the labyrinth.

That present was very small in all

but a few experimental and control placentae which contained somewhat
more.

The yolk sac villous cells uniformly showed a picture of sub-

stantial accumulations in the apical cytoplasm of each cell.
The glycogen-bearing cells in the spongy zone appeared maximally
intense.

Consistent with the

micro~eter

measurements, the amount of

cells with glycogen was approximately similar in controls and experimentals.

The amount of such cells present became progressively less

from group I to group IV (Figures 18,19,20,21).

This is consistent

with the disappearance of glycogen with advancing gestation.
In all four groups, placentae of experimentals and controls treated
with diastase and stained with PAS, revealed that the decidua, giant
cell zone, spongy zone, and yolk sac were respectively similar.
In the decidual zone there was an abundance of magenta-colored,
amorphous neutral mucopolysaccharides present in the
between the junctional zone cells.

conn~ctive

tissue

In the giant cell zone, each giant

cell was· rimmed with this magenta-colored material in the connective
tissue.

In the spongy zone, each cell, in the sheets of non-glycogen-

containing cells, contained a connective tissue matrix of the brightcolored magenta material like that in the giant cell zone.

In many

r
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specimens, the connective tissue around glycogen-bearing cells was
also stained.

Variable intensities of amorphous, bluish-purple material

containing both acid and neutral mucopolysaccharides were observed in
both experimentals and controls.
discerned.

Patterns of depositions could not be

In the yolk sac, the villous cell tips contained much

neutral mucopolysaccharide, and Reichert's membrane stained bright
magenta throughout.
The labyrinth in the experimentals of group I and II contained
more neutral substance than did that of controls.

In group III, the

experimentals contained more neutral mucopolysaccharide than did the
controls.

(Unfortunately, the fetuses of these animals died.)

IV was similar to groups I and II.

Group

Generally, as one proceeded from

group I to group IV, more neutral polysaccharides were observed in both
experimentals and controls.

No distinct orientation of deposits to

either maternal or fetal face, central or peripheral locales in the
labyrinth was observed.
~~hromasia ~

Deposits were mostly widely scattered.

Basophilia

Toluidine blue is an aniline dye used for locating cellular and
extra-cellular basophilia,due,for instance, to ribonucleoproteins and
mucopolysaccharides containing acid groups.

A metachromatic color

change in the dye from blue to purplish-red indicates the P.resence of
strongly-acidic

substances!.·~·

acid mucopolysaccharides.

In all four groups minimal appearances of metachromatic material
were observed in both experimentals and controls.

The trace- substances

that were observed were irregularly present and not confined to a
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specific location.
Similarly in groups I, II, IV, and part of III minimal intensities
of basophilic material were observed sporadically in both experimental
and control specimens.

In group III the placentae of Nos. 9, 10, 11,

and 12, which bore dead fetuses at necropsy, showed slight increases
of stromal basophilia, and placentae from No. 10 showed the extensive
testimony of nuclear fragmentation in the labyrinth that accompanies
cellular degeneration.
Calcium
Observations on the occurrence and distribution of insoluble calcium deposits were limited to the 12 control and 24 experimental placentae fixed in alcohol formalin in order to avoid possible false localization attendant upon the use of the other two fixatives.

Of the fbur

possible staining methods utilizing GBHA, recommended by Kashiwa and
House ( 1 64) 1 the "flooding method with solution II" gave the best
results.
Hydroxyurea-treated specimens from all four groups showed increased
evidence of insoluble calcium deposits in the placenta.

In group I,

control specimens contained no evidence of calcium except for No. 13A
which had one small reddish-brown area in the middle of the labyrinth.
Experimental placentae contained heavy but not extensive calcium deposits in the labyrinth, villous and Duval cells of the yolk sac, giant
cell zone, and decidua basalis.

In these and placentae from subsequent

groups, calcium deposits in the labyrinth were mainly oriented toward·
the fetal face and toward the center of the section.
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In group II, control placentae were again devoid of stainable calcium whereas experimentals contained small deposits in the giant cell
zone and labyrinth.
In group III, control specimens contained no evidence of calcium
except for a heavy, concentrated intensity in a necrotic area near the
fetal face of the labyrinth of No. 21C.

Placentae from animals Nos. 9,

10, 11, and 12, which bore dead fetuses at necropsy, showed more extensive evidence of calcium than did Nos. 22, 23, and 24 which were alive
at necropsy.

Calcium deposits in group III were observed mainly in the

labyrinth along the fetal face with the spongy zone and giant cell zone
containing only a few small deposits.

No. lOC contained the most exten-

sive evidence of calcium in the labyrinth (Figure 22).
In group IV, control specimens contained some calcium in the giant
cell zone and decidua basalis whereas experimental specimens showed
evidence of stainable calcium in the villous and Duval cells of the
yolk sac and in the giant cell zone.

DISCUSSION

Fetuses
This study of rat conceptuses following the administration of
2000mg/Kg or 2500mg/Kg of HU intraperitoneally during the latter third
of gestation, was designed to reinvestigate and expand a part of Gaik's
( 1

67) studies.

Gaik administered two doses of HU to two pregnant albino

rats, one on the 14th and 17th and the other on the 16th and 19th days
of gestation.

Enormous fetuses were produced whose crown-rump length

and weight far surpassed that of fetuses from control animals.

Abnor-

malities such as an edematous appearance, short stubby somewhat malformed limbs and snout and an enlarged thorax were also observed in
these overgrown fetuses.

Similar abnormalities were observed in this

study but with fetuses which were within normal weight and length range.
The enlarged thoracic and shoulder region that we observed was shown to
be produced largely by extensive edema in the subcutaneous tissue;
although this edema was not limited to the above region (Figure 4).
An hypothesis to account for the fetal edema might be developed

--

from the work of Sinclair ('67) and of Adamson et al. ( 1 65).

Sinclair

found that when the cells of the Chinese hamster, grown in vitro, were
exposed to 1.0 ruM of HU for 1.2 hours only those cells in the DNA replication·phase (S) of the ~ell cycle failed to divide.

While these

cells did resynthesize DNA after drug removal, they enlarged three to
four times their normal volume in the next 20-30 hours and then lysed.
30
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In this thesis and in that of Gaik the amount of HU that reaches the
fetuses is unknown as is the rate of its metabolism by both mother and
fetuses.

However,

Adamson!.!.~·

( 1 65) found that in non-pregnant rats

and mice 70% of the HU, in a dose of 200-500mg/Kg, was excreted in the
urine in three hours and 90% in 24 hours.

If the in vivo metabolism of

HU in rats and mice was similar to the in vitro behavior of hamster
cells, cellular breakdown products resulting from cell lysis would be
released in the intercellular spaces there lowering water concentration
extrecellularly, thereby attracting water from the cells and thus producing edema.

Twenty-four hours after the second injection necropsy was

performed; this time lapse might have permitted the second injection of
HU to have a lysing effect on more cells.

Both injections then could.

have had a combined effect to produce the fetal edema observed.
It was also observed that the teratogenic effects displayed by
these fetuses were mild compared to the effects observed by Murphy. and
Chaube ('64) on younger rat embryos.

They observed that pregnant rats

given 50-2000mg/Kg of HU on the 9th to 12th days, and then necropsied
on the 21st day of gestation had fetuses which were retarded in growth
and had a, cleft palate, encephaly, hairlip, retarded clubbed fore and
rear appendages and a retarded tail.
Pl'.acental Morphology
The .morphological and·histochemical changes in placentae after
treatment with HU are· similar in some respects to those obtained by
Gaik ('67) whose work this thesis was designed to reinvestigate and
extend •.
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The placentae of treated animals were flattened and more cup-shaped
and appeared to be of greater diameter than control placentae.
actual measurement proved that the diameters were similar.

I~we~er,

Gaik had

observed that for single and multiple-injected animals the placentae
appeared flatter and smaller than those of control animals.
Jollie ('64L),in a radioautographic study of DNA synthesis in the
rat placenta with tritiated thymidine, observed that no labelling of
the nuclei in the labyrinthine trophoblast and yolk sac endoderm occurred after the 12th day of gestation.

This

sug~ests

that no DNA syn-

thesis and therefore no mitosis would occur after this time in these
regions.

Gaik's observations on the presence of mitotic figures con-

firms these observations.

However, in the present work mitotic figures

were observed in both the labyrinth and yolk sac not only on the terminal day but also on the 18th and 20th days in both treated· and control
specimens.

This suggests that no long lasting interference of mitosis

in the labyrinth and villous yolk sac by HU occurred.
Measurements of the width of the labyrinth showed a decrease in
experimental placentae.

Accompanying this decrease, however, there

appeared to be an increase in the nurnber of cells in the field of view
in many areas of the labyrinth.

HU acts mainly on rapidly dividing

cells but Bridgeman ( 1 48), ~ollie ('64), and Gaik ('67) did not observe
mitotic figures in the labyrinth during this latter third of gestation.
The mitotic figures

~bserved

in this work were minimal in number and

should not have been expected to appreciably alter the zone size if
acted· upon by HU.

However, in the case of group I, treated on the 14th
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and 17th days, if an appreciable number of dividing cells were present
on the 14th day then the action of HU on these cells might account for
the large decrease in width observed in the labyrinth of this group.
Similar to Sinclair's ('67) experience with dividing cells of the
Chinese hamster,

i·~·

those cells grown in vitro and exposed to HU, one

might expect a concommitant increase in the amount of cellular fragmentation, which would be observed as Feulgen-positive, basophilic accumulations in the labyrinth, if a similar swelling and lysis had occurred
here.

No increase was observed in groups I, II, IV, and part of III.

Nos. 9 1 10, and 12 of group III showed a slight increase in the intensity of basophilic deposits present and No. 10 showed extensive accumulations in the labyrinth.
all dead at necropsy.

The fetuses from this group of animals were

Emmert ('57), after fetalectomy in the cotton

rat, observed an increase in Feulgen-positive nuclear debris together
with Feulgen-negative, granular basophilic accumulations in the labyrinthine connective tissue which were accompanied by increased iron and
calcium deposits.

These accumulations were observed as soon as six

hours after fetalectomy and became quite intense and widespread with
time.

It appears tenable that those placentae here investigated which

showed increased accumulations did so due to the fetoplacental dissociation and not to the HU whose affects appear to have resulted in a
retraction of the fetal vascular tree with its accompanying, thickened,
trophoblastic plates, irregular maternal face of the sinuses, apparent
increased cellularity, and torn fetal capillary endothelium.
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Iron
The moderate to substantial accumulations of blue ferric ferrocyanide deposits in the yolk sac villous cells of experimental placentae
in all four groups confirms the results obtained by Gaik ('67) in
animals given two injections.
It is unkno\m whether HU had any effect on the transfer or rate of
transfer of iron across the placenta.

Glasser et al. ('68) observed

that there is a large increase in radioactive iron (Fe
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.

) trans.:f'er

from days 14 to 16 and this is coincident with the start of hemopoiesis
by the fetal liver.
nor yolk sac

This group also observed that neither the placenta

possess~d

a large capacity to retain the iron isotope.

They reported that the greatest intensity of iron found in the yolk sac
occurred on the 14th day after which the iron content fell markedly.
Nylander ('53), on the other hand previously suggested that the yolk
sac served as a storage depot for iron, especially near. term.

The yolk

sacs of control animals utilized for this thesis were devoid of ferric
ions.

Placentae from all experimental animals contained moderate to

substantial deposits of iron in the yolk sac villous cells and lesser
amounts in the labyrinth.

Gaik ( 1 67) obtained similar results after

both single and multiple doses of HU.

Also Emmert ('57) and Glasser

et al. ( 1 68) observed increased placental iron accumulations after
fetalectomy.

The results ·of the latter two investigators suggested

that the ability of.the placenta to remove

i~on

from the maternal blood

stream is an active process and not dependent on an intact fetus.
The fetuses in this work were alive except for those in animals
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from group III Nos. 9 1 10, 11, and 12.

Information at hand suggests

that the accumulation of iron in the placenta could be caused by polyanionic compounds in the placenta which attract and bind the cation or
that there is a derrangement in the transfer of iron from the placenta
to the fetal blood.

The results of the metachromatic stain, toluidine

blue, for acid containing compounds, was too capricious to allow a
determination as to whether an increased amount of polyanionic substances, such as acid mucopolysacharides were present to bind the ferric
ions.

Laurel! and Morgan ('64), using 20-day pregnant rats, observed

that iron is transferred from maternal plasma transferrin to the placenta and then to fetal plasma transferrin.

Possibly, HU may have

altered the transfer mechanism from the placenta to the fetal blood,
or the combi,nation of a possible increase in anions and an altered
transfer mechanism teamed-up to produce the results obtained.

Present

knowledge concerning the effects and mechanisms of HU action prevents
any complete explanation as to why increased iron was found in the
placentae of the experimental animals.
Glycogen
The distribution and rate of disappearance of glycogen in the control and experimental placentae studied is similar to that observed by
other investigators (Wislocki, Deane, and Dempsey, '46), (Bridgeman,
1

48), (Amoroso, '52), and .(Gaik, '67).

A great intensity of glycogen

was observed in the _junctional zone of the decidua basalis, in the
epithelium of the villous portion of the yolk sac and in the spongy
zone on the 18th day of gestation.

In the labyrinth, a few small and
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and widely separated glycogen deposits were observed in some experimental and control specimens from each group.

By the 21st day of ges-

tation, most of the glycogen disappeared from the glycogen-bearing cell
zone (Figures 18,19,20,21) and from the endodermal cells of the villous
yolk sac.
As previously reported, HU was not expected to have any effect on
the glycogen-bearing cells since by the 14th day no mitoses are observed
in these cells (Bridgeman, '48).

Observations and measurements of the

quantity and distribution of such cells in the spongy zone corroborated
this thought.

Gaik ('67) observed the absence of glycogen-containing

cells from the spongy zone after injection of 2000mg/Kg of HU on the
14th and 17th days of gestation and necropsy on the 18th day.

She

suggested that glycogen stores were depleted to feed the outsized
fetuses from that animal.
Metachromasia and Basophilia
In order to determine the amount of metachromatic substance in the
placenta, specimens were stained with 0.06% toluidine blue at pH 3.5.
When certain aniline dyes are bound to particular substrates they exhibit characteristic color changes known as metachromasia.

These sub-

stances include nuclear and cytoplasmic ribonucleoproteins and sulfate
esters of high molecular weight as are found in acid mucopolysaccharides
(Bergeron and Singer, '58)..
The results obtained in this work were essentially the same as
those observed by Gaik ('67),

!•~t

metachromasia never abounded in any

specimens and its presence was canricious.

In Nos. 9 9 10, 11, and 12,
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slightly incre.ased deposits were observed, and in No. 10 extensive
basophilia was observed in the stroma of the labyrinth.

It should be

reiterated that these fetuses were dead at necropsy.
Calcium
Emmert observed a significant relationship between fetal distress
and placental calcification in the cotton rat ( 1 57) and in the albino
rat ( 1 58).

After feto-placental dissociation in these animals increases

of soluble calcium were observed in the stromal tissue of the labyrinth.
These deposits continued to increase in intensity of staining and in
distribution as long as the maternal blood: supply to the placenta was
maintained.
The increased calcification observed in the labyrinth of experimental specimens suggests that this is not a normal occurrence in the
aging rat placenta of this strain.

Wislocki et al. ( 1 46) working with

rats (strain unspecified), observed that argyophilic deposits, soluble
in aqueous acids, were present in the decidua basalis and junctional
zone of the aging placenta.

They concluded that these deposits repre-

sented deposits of calcium.

When degenerative changes occur in cells

as they do here polyanionic substances such as nucleoproteins are freed
and, along with other anions, already present in the stroma, like acid
mucopolysaccharides, are able to attract cations, !.•K.! Ca ++ and Fe +++ •
In the junctional zone,

de~idual

cells eventually degenerate and one

might expect to observe calcium deposition in this area.

In the pla-

centae analyzed' here similar deposits were observed but not extensively
along the described margin of the placenta.
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Using the Dahl method for calcium, Gaik ('67) did not observe
calcium in the control placentae removed for study from animals necrop.sied on the 19th and 20th days of gestation.

She did find that in

animals injected with a single dose of either 2000mg/Kg or 2500mg/Kg
of HU on days 14 to 16 the placentae contained substantial calcium
deposition in the spongy zone, labyrinth, and in necrotic areas in the
labyrinth.

Placentae from an animal injected on the 18th day with

21-74mg/Kg showed no deposits.

Of the two animals receiving multiple

doses of HU the animal injected with 2000mg/Kg on the 14th and 17th
days showed substantial accumulations in both the labyrinth and spongy
zone while the animal treated on the 16th and 19th days with 2500mg/Kg
showed only barely discernible amounts in these areas.
No evidence of extensive cellular degeneration in the labyrinth
was observed in any animal except No. 10 of group III which contained
dead fetuses at necropsy.

Increased basophilia was observed in these

placentae along with extensive areas of calcification in the fetal
connective tissue of the labyrinth (Figure 22).

Greater deposits ot

calcification were observed in Nos. 9, 11, and 12 of group III than in
all the other placentae, but none was as extensively calcified ns No.
10.

Concomitently, a slight increase in the amount of discernible

acid substances was observed in the placentae of the above three animals
Since consistent and wide-spread increased calcification was
observed in this study, only in those placentae whose fetuses were dead
a necropsy, it is

pres~med

that the fetoplacental dissociation,

!·~·•

the absence of 'fetal blood flow, is the major factor in producing this
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calcification, and further that the thickened labyrinthine plates, the
irregular maternal face of the sinuses, the apparent increase in cellularity, and the separated capillary endothelium, are_ alterations of
placental morphology brought on by the retraction of the fetal vascular
tree and its stroma, and as such are not necessarily a primary affect
of HU.

The sporadic occurrance of calcium in the labyrinths of the HU

treated specimens is probably due to localized defects in the fetal
vascular tree.
Certainly, in early gestation HU acts to produce bone defects
(Murp~y

and Chaube,

1

64), but whether or not HU has a metabolic effect

on the utilization of calcium and iron is not known.

We do know, how-

ever, that the treatment with HU occurred at a time when the placental
transfer of calcium (Feaster,
(Glasser et al.,

1

1

56), (Wasserman !!_

68) is at its highest.

~·,

'57) and iron

SUMMARY AND CONCLUSIONS

1.

The placentae and fetuses of albino pregnant rats treated with
Hydroxyurea during the latter part of gestation were investigated
both histologically and histochemically.

2.

\Veight gain in treated mothers was approximately half that of nontreated control mothers.

3.

The average weight and length of

f~tuses

from treated mothers was

less than for those of control specimens, but still within normal
limits.
4.

Fetuses examined under the dissecting microscope showed underdeveloped ear flaps, short stubby snout and appendages, enlarged
thoracic and shoulder area, and stretched skin.

The latter two

changes were caused by extensive edema observed under the skin and
in the body cavities.
5.

Treated placentae had lost their button-like shape and appeared
flattened and shaped more like a shallow cup.

6.

Diameters of treated and non-treated specimens were compared and
found to be similar.

7.

When the widths of the spongy zones and labyrinths were measured at
mid-placentID, the spongy zones were found to be similar in size
whil~

the labyrinths were smaller in experimental than in control

placentae.
8.

The labyrinth appeared to be pulled together (retracted) in treated
40
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placentae.

Trophoblastic cells appeared farther apart and meso•

dermal cells appeared closer together; the labyrinthine plates
appeared thicker and the maternal face of the sinuses presented an
irregular surface.
9.

Mitoses were observed in minimal numbers in the trophoblastic and
mesodermal cells of the labyrinth as well as in the endodermal
cells

10.

or the villous yolk sac.

Increased iron deposits were observed in the villous yolk sac and
labyrinth in experimental conceptuses.

11.

No change in the glycogen deposition or its disappearance was
observed after treatment with HU.

However, the neutral mucopoly-

saccharide content did show some increase.
12.

Metachromasia, following buffered toluidine blue staining, was
highly variable and histotechnically difficult to evaluate.

An

increase in acid mucopolysaccharides appears likely in view of the
binding of calcium and iron in the connective tissue.
13.

The increased calcium, iron, and granular basophilic accumulations
which were observed in the labyrinths of conceptuses bearing dead
fetuses in treated rats were similar to those observed by Emmert
( 1

14.

57) following surgical feto-placental dissociation.

In the treated placentae, whose fetuses were alive at necropsy,
the localized alterations in the labyrinthine stroma are interpreted as resulting from limited defects in the fetal circulation and
may reflect early signs of impending fetal distress.
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TABLE I

MATERNAL WEIGHTS OF RATS ON DAYS OF INJECTION A!\1> AT N£CROPSY
FOLLOWING MATERNAL TREATME:-T DURING GESTATION \HTH HYDROXYUREA
GROUP,
RAT NO.

DOSE

GESTATION
DAY INJ.

WT. AT

EA.

INJ.

WT. AT

GESTATION

NECROPSY

DAY NECROPSIED

I

2000
mg/Kg

2000
mg/Kg

18.
18
18
18

15, 18#

300, 350

15, 18
15, 18

310, 330
280, 260

370
374
340
284

20
20
20
20

16, 19#

310, 360
278
356
324
330
356
326
348

366
374
290
350
324
350
344
330
340

20
20
20
20
20
20·
20
20
20

30?, 316
295, 270
293, 323

362
300
316

21
21
21

20
4*
6
8

III
21
4

2500
mg/Kg

337
324
288
304

14,
14,
14,
14,

II

17#
17#
17
17

327
318
287
314

13
15
14
16

19
19
19
19
19
19
19

10
11
12
22
23
24

16,
16,
16,
16,
16,
16,
16,

17
18
19

17, 2cl
17, 20
17, 20

9

282,
280,
261,
283,

242,
304,
298,
294,
320,
300,
318,

IV
2000
mg/Kg

#

= vehicle

control '(boiled distilled water)

•· = non-treated

control

TABLE II
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THE CONDITION AND NUMBER OF FETUSES AT NECROPSY FOLLOWING
MATERNAL TREATMENT DURING GESTATION WITH HYDROXYUREA
GROUP

RAT NO.

NO. FETUSES

LIVING

·DEAD

RESORBED DEAD

I: Rx
14, 17th
days with
2000mg/Kg

N*, 18th
day.

II: Rx
15; 18th

days with
2000mg/Kg
N, 20th
day.

III: Rx
16, 19th
days with
2500mg/Kg
N, 20th
day.

IV: Rx
17, 20th
days with
2000mg/Kg
N, 21st
day.

13#
15#
14
16

11
11
11

11
11
11

0
0

9

8

1

. 20#
4##
6
8

12
10
12
10

12
10
12
10

0
0
0
0

0
0
0

21#
4tl#

11
10
10
14

0
0
10
12
8
13
0

0
0
0
2

13
11
10
12

11
10
0
0
0
0
11
9
12

10

10

3

3

12

12

0
0
0

9

10
11
12
22
23
24

17#
18
19

8

• = Necropsied
= Vehicle control (boiled
## = Non-treated contro~

#

distilled water)

0

0

0

0

0
0
0

0

0

0
0
1
0

0

0
0

TABLE III
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WEIGHT AND CROWN-RUMP LENGTH OF FETUSES AT NECROPSY FOLLOWING
MATERNAL TREATMENT DURING GESTATION WITH HYDROXYUREA
AVE. WT.

GROUP

RAT NO.

I: Rx

14, 17th
days, N*,
18th day.

13
15
14
16

-DOSE

IN GM.

veh. cont. #
veh. cont.
2000mg/Kg.
2000mg/Kg

RANGE
IN GM.

AVE. LENGTH
IN MM.

RANGE
IN MM.

1.56
1.64
1.34
1.49

1.06-2.08
1.45-1•80
0.10-1.11
1.35-1.77

25.0
24.0
20.0
19.0

22-28
22-26
10-22
17-22

4.06
4.15
1.74
1.93

1.24-4.74
4.00-4.68
1.44-2.13
1.65-2.56

36.6
35.5
26.5
27.0

25-40
29-39
24-29
26-29

4.05
4.16
2.70
2.62
2.42
2.51
3.43
3.52
3.50

3.70-4.36
4.00-4.68
2.16-3.34
1.31-3.46
2 .14-2.80
1.90-3.22
2.88-3.85
3.20-4.30
3,00-3.98

36.8
35.5
28.5
28.1
29.4
27.0
32.4
34.5
32.0

36-38
29-39
26-30
28-31
26-31
25-30
30-39
32-41
29-34

5.71
5.28
4.99

5.03-6.05
5.24-5.36
4.76-5.34

43.5

38-44
38-44
37-44

II: Rx
15, 18th
days, N,
20th day.

20
4
6
8

veh. cont.
-##
2000mg/Kg
20.00mg/Kg

III: Rx

16, 19th
days, N,
20th day.

21
4
9

10
11
12
22
23
24

veh. cont.
2500mg/Kg
2500mg/Kg
2500mg/Kg
2500mg/Kg

2500mg/Kg
2500mg/Kg
2500mg/Kg

IV: Rx
17, 20th
days, N,
21st day •.

17
18
19

2000mg/Kg

2000mg/Kg
2000mg/Kg

• = Necropsiedl
# : Vehicle control (boil.ed
t#f.

= Non-treated

control

distilled water)

~1.3

41.7

so·
TABLE IV
A

COMPARISON OF PLACENTAL DIAMETERS FROM CONTROL
ANIMALS AND THOSE TREATED WITH HYDROXYUREA

EXPERIMENTAL

GROUP

CONTROL

I: Rx

14, 17th
days with
2000mg/Kg
N*, 18th
day.

No. ot
7.5-llmm

17
8-llmm

9.4mm

9.6mm

14
8-llmm
9.0mm

13
7-12mm
10.5mm

specimens
Range
Average

55
8-14mm
11.lmm

12

No. ot
specimens
Range
Average

10
9-llmm
9.Smm

7

specimens
Range
Average

17

II: Rx

15, 18th
days with
2000mg/Kg·
N, 20th
day.

No. ot
specimens
Range
Average

III: Rx

16, 19th
days with
2500mg/Kg
N, 20th
day•

No. of
9.5-12mm
10.911111

IV: Rx

17, 20th
days with
2000mg/Kg
N, 21st
day.

• = Necropsied

8-1llltlll
10.0mm
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TABLE V
A COMPARISON OF THICKNESS OF LABYRINTHS AND SPONGY ZONF.S
IN PLACENTAE FROM CONTROL AND HU TREATED ANIMALS

GROUP

LABYRINTH
EXP'T.
CONTROL

SPONGY ZONE
EXP' T.
CONTROL

17
o.3s-1.2s

I: Rx

14, 17th

No. ot

daya with
2000mg/Kg

specimens
Range (mm)

17

N•, 18th
day.

% change

Ave.••(~)

1.63

II: Rx
15, 18th
days with
2000mg/Kg
N, 20th
day.

1.00-2.25

17
1.13-3.50
2.26.

o.1s

17
o.50-1.38
o.74

No change

28% decrease

No. ot
specimens
Range (mm)
Ave. (mm)

% change

1.25-2.50
1.88-2.70
2.15
2.38
10% decrease

13
o.3s-o.75
0.10
o.48
30% increase

55
12
1.25-2.88
l.00-3.28
1.99
2.30
14% decrease

55
12
o.31-0.88 o.3s~o.75
o.54
o.57
5% decrease

10
7
1.75-2.38
2.25-2.75
2.28
2.54
100"' decrease

10
o.3s-o.5o

14

13

14
o.3s-1.oo

III: Rx
16, 19th
days with
2500mg/Kg
N, 20th
day.

No. ot
specimens
Range (mm)
Ave. (mm)

%'change

IV: Rx
17, 20th
days with
2000mg/Kg
N, 21st
day.

No. of
specimens
Range (mm)
Ave. (mm)

% change

• = Necropsied
•• = Average
# = (Experimental/Control)

x 100

0.42

7

o.38-0.63

o.so

16% decrease
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TABLE VI
HISTOCHEMICAL LOCATION OF IRON DEPOSITS

GROUP

ZONE

I: Rx
14, 17th
days with
2000mg/Kg
N*, 18th
day.

GIANT CELL ZONE
SPONGY ZONE
LABYRINTH
YOLK SAC
DEC I DUA

T,V
T,V

GIANT CELL ZONE
SPONGY ZONE
LABYRINTH
YOLK SAC
DECIDUA

T,V
T,V

GIANT CELL ZONE
SPONGY ZONE
LABYRINTH
YOLK SAC
DEC I DUA

T,VT,V

GIANT CELL ZONE
SPONGY ZONE
LABYRINTH
YOLK SAC
DECIDUA

T,V
T,V
v

II: Rx
15, 18th
days with
2000mg/Kg
N, 20th
day.

v

+

++

+++

v

T
T

T

T,V

v

v

v

T

T

T

T

T

T

T

T

III: Rx
16, 19th
days with
2500mg/Kg
N, 20th
day.

IV:

v
v

T,V
T,V

Rx

17, 20th
days with
2000mg/Kg
N, 21st
day.

• = Necropsied
Placentae treated

-

+
++
+++

T,V
T,V

with Hydroxyurea
Placentae tr~ated with vehicle
Iron deposits not present
= Trace
amounts of ferric iron present
= Moderate
amounts of iron present
=
= Substantial amounts of iron present

T =

v

v

=

TABLE VII
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HISTOCHEMICAL DETECTION OF GLYCOGEN BY PAS

ZONE

GROUP

+

++

+++

++++

I: Rx

14, 17th
days with
2000mg/Kg

N•,

18th

day.

GIANT CELL ZONE

T,V

SPONGY. ZONE

LABYRINTH
YOLK SAC
DECIDUA

T

v

T,V cell

T,V
_T,V

II: Rx

15, 18th
days with
2000mg/Kg

N, 20th
day.

III: Rx
16, 19th
days with

GIANT CELL ZONE
SPONGY ZONE
LABYRINTH
YOLK SAC

GIANT CELL ZONE

2500mg/Kg
N, 20th

day.

DECIDUA

IV: Rx
17, 20th
days with

GIANT CELL ZONE
SPONGY ZONE

2000mg/Kg

LABYRINTH
YOLK SAC
DECIDUA

• = Necropsied
= Placentae treated
= Placentae tre.ated

T
V

-

+

++
+++
++++

T

v

T,V cell

T,V
T,V

DEC I DUA

SPONGY ZONE
LABYRINTH
YOLK SAC

N, 21st
day.

T,V

T,V
T

v

T,V cell

T,V
T,V

T,V
V

T,V cell
T

with Hydroxyurea
with vehicle
= Glycogen not present
= Trace amounts of glycogen present
= Moderate amounts of glycogen present
= Substantial amounts of glycogen present
= Heavy amounts of glycogen present

T,V
T,V
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FIGURE 1:

Histology of the normal albino
rat placenta on the 20th day
of gestation.
Hematoxylin and Eosin

16X

LA = Labyrinth

sz

= Spongy zone

GC = Giant cell zone
DB = Decidua basalis

"
FIGURE 1
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FIGURE 2:

Fetuses from experimental (E) and control
(C) animals which were alive on day 21 of
gestation.

Experimental injected on 17th,

20th days with 2000mg/Kg of HU.

Observe

underdeveloped fore and rear appendages,
snout, and ear flaps; and the enlarged
thoracic region and stretched skin of the
experimental fetus.
Formalin fixed

l.3X

FIGURE 2

FIGURE 3:

Fetus from an experimental animal on 20th
day of gestation after treatment with
2500rng/Kg of HU on 16th and 18th days.

The

most marked evidence of resorption in this
study.
Formalin fixed:

l.3X
FIGURE 3
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FIGUIIB 4:

Posterior view of a cross section of
20 day control (left) and experimental
(right) fetuses at the level of the forearms
showing accumulation of fluid (l' ~) just
beneath the skin on the experimental fetus.
This fetus was exposed to 2500mg/Kg of HU
on the 16th and 19th days of gestation.
Formalin fixed
2X

FIGURE 4
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The following Fi g ures 5 through 8
\llustrate the flattening of the placental
disc following trea tment with HU as
.,
In each instance the
indicated below.

FI GURE 5

control placenta is on the left and the
experimental placenta is on the right.

FIG. 5:

Group I, treated 14th, 17th days
with 2000mg/Kg, necropsied _18th day.

FIGURE 6
FIG. 6:

Group II, treated 15th, 18th days
with 2000mg/Kg, necropsied 20th day.

FIG. 7:

Group III, treated 16th, 19th days
with 2500mg/Kg, necropsied 20th day.

FIG. 8:

Group IV, treated 17th, 20th days

FIGURE 7

with 2000mg/Kg; necropsied 21st day.
Hematoxylin and Eosin
4X

FI GURE 8
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FIGURE 9:

Placental labyrinth on 18th day of
gest~tion

showing thickened placental

membranes (shown between arrows) after
~ treatment

with 2000rng/Kg of HU on 14th

and 17th days of gestation.
Hematoxylin and Eosin

•

488X

FIGURE 9

FIGURE. 10:

Placental labyrinth on 18th day of
gestation showing normal placental
membranes (shown between arrows) after
treatment with boiled distilled water

I

on 14th and 17th days of gestation.
Hematoxylin and Eosin
488X .

FIGURE 10
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FIGURE 11:

Placentnl labyrinth on 20th day of gestation
showing thickened placental membranes (shown
'between arrows) after treatment with 2500rng/Kg
of HU on the 16th and 19th days of g~station.
Fetuses of the placentae of these rats were
dead at maternal necropsy.
Hematoxylin and Eosin

FIGURE 11

488X
FIGURE 12:

Placental labyrinth on 20th day of gestation
showing the lack of effect of boiled distilled
water (BU vehicle) on the placental membranes
(shown between arrows) after treatment on 16th
and 19th days of gestation.
Hematoxylin and Eosin

488X

FIGURE 12
FIGURE 13:

Placental labyrinth on 20th day of gestation
showing thickened placental membranes (shown
between arrows) after treatment with 2500mg/Kg
of HU on the 16th and 19th days of gestation.
Fetuses of the placentae of these rats wer&
alive at maternal necropsy.
Hematoxylin and Eosin

488X

FIGURE 13
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FIGURE 14:

Mitotic figure in trophoblastic
cell of the labyrinth in a
control placenta on the 18th
day of gestation.
Feulgen
l084X

FIGURE 1 4

FIGURE 15:

Mitotic figure in an endodermal
cell of villous yolk sac from a
non-treated control placenta on
18th day of gestation.
Feulgen
l084X

FIGURE 15
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FIGURE 16:

The villous yolk sac placenta on the
~ 20th

day of gestation showing absence

of iron in a control animal.
Gomori modification of Perls' method.
488X

FIGURE 1 6

FIGURE: 17:

The villous yolk sac placenta on the
20th day of gestation showing deposits
or iron (ID) after treatment with
2500mg/Kg of HU . on the 16th and 19th
days of gestation.
Gomori modification of Perla' method.
488X

FIGURE 17
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FIGUru:: l~:

Glycogen-bearing cells (Gl C) in the spongy
zone of the placenta on the 18th day after
treatment with boiled distilled water (the
vehicle) on the 14th and 17th days.

FIGURE 19:

Glycogen-bearing cells (Gl C) in the spongy
zone of the placenta on the 18th day after
treatment with 2000xng/Kg of HU on the 14th
and 17th days.

l<"'IGURE 20:

Glycogen-bearing cells ( Gl C) in the spongy

FIGURE 18

FIGURE 19

FIGURE 20

FIGURE 21

zone of the placenta on the 21st day after
treatment with boiled distilled water (the
vehicle) on the 17th and 20th days.

FIGURE 21:

Glycogen-bearing cells (Gl C) in the spongy
zone of the placenta on the 21st day after
treatment with 2000mg/Kg

~f

HU on the 17th

and 20th days.
Hematoxylin and Eosin
43X·
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FIGURE 22:

Strornal calcification (1') of a
placental labyrinth associated
with a dead fetus after treatment
on the 16th and 19th days of
gestation with 2500mg/Kg of HU
and necropsied on the 20th day.

GBHA
631X

FIGURE 22

APPROVAL SHEET

This thesis submitted by Michael R•.Cozza Jr. has
been read and approved by three members of the faculty
of the Graduate School.
The final copies have been examined by the director
of the thesis and the signature which appears below
verifies the fact that any necessary changes have been
incorporated, and that the thesis is now given final
approval with reference to content, form and mechanical
accuracy.
The thesis is therefore accepted in partial
fulfillment of the requirements for the Degree of
Master of Science.

7n7

1..r

mi
Signature of Adviser

Date

74

